Magnezu Siarczan

Magnesium sulfate heptahydrate, the active ingredient in Magnezu Siarczan, is a mineral supplement presented as an oral powder for oral use. It is employed to address magnesium deficiency, hypomagnesemia, and to provide electrolyte replacement, and it also acts as an osmotic laxative when taken orally.

GNH USA supplies Magnezu Siarczan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnezu Siarczan is a mineral supplement that supports electrolyte balance and gastrointestinal function. - Magnesium deficiency: restores normal magnesium levels and alleviates related symptoms. - Hypomagnesemia: corrects low serum magnesium in clinical settings. - Electrolyte replacement: replenishes magnesium as part of broader electrolyte therapy. - Osmotic laxative: promotes bowel movements by drawing water into the intestinal lumen.

Magnezu Siarczan may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Diarrhea: loose stools occurring shortly after ingestion. - Abdominal cramping: discomfort or pain in the stomach area. - Nausea: feeling of unease or urge to vomit. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Hypermagnesemia: elevated blood magnesium that can affect cardiac and neuromuscular function. - Severe dehydration: excessive fluid loss due to prolonged diarrhea. - Allergic reaction: rash, itching, or swelling of the face, lips, or throat. - Hypotension: unusually low blood pressure, especially in susceptible individuals.

Before using Magnezu Siarczan, consider the following safety measures. - Assess serum magnesium: verify baseline levels to guide appropriate use. - Monitor renal function: impaired kidneys may reduce magnesium clearance. - Use caution in cardiac conduction disorders: excess magnesium can affect heart rhythm. - Avoid in severe dehydration: risk of further fluid loss and electrolyte imbalance. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Magnezu Siarczan can interact with several medications; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Neuromuscular blocking agents: magnesium may potentiate their effect, leading to prolonged paralysis. - Tetracycline antibiotics: magnesium can chelate the drug, reducing its absorption. - Bisphosphonates: concurrent intake may diminish bisphosphonate efficacy.

Moderate Interactions (Monitor Closely): - ACE inhibitors and ARBs: combined use may increase the risk of hypermagnesemia. - Loop and thiazide diuretics: may alter magnesium balance, requiring closer monitoring. - Oral contraceptives: magnesium may affect hormone levels, warranting observation.